Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 24Thoracic 17Gynecologic 6Tumor-Agnostic 5Gastrointestinal 3Genitourinary 2Sarcoma 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 35Osteosarcoma 22Central Nervous System Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Colonic Neoplasms 5Pancreatic Neoplasms 4Neuroblastoma 4Gliosarcoma 4Glioma 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Astrocytoma 4Wilms Tumor 3Sarcoma, Ewing 3Rhabdomyosarcoma 3Rectal Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Ependymoma 3Desmoplastic Small Round Cell Tumor 3Choroid Plexus Neoplasms 3Carcinoma, Ovarian Epithelial 3

Interventions

pembrolizumab 3Oncolytic Virotherapy 2Fluorouracil 2Cyclophosphamide 2Cetuximab 2trebananib 1spartalizumab 1repotrectinib 1pemigatinib 1patritumab 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1darinaparsin 1apatinib 1Tetanus Toxoid 1Sirolimus 1Paclitaxel 1Mesna 1Ipilimumab 1Injections 1Etoposide 1Cisplatin 1Celecoxib 1Carboplatin 1Blood Specimen Collection 1Ascorbic Acid 12,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Cisplatin × Sarcoma × Clear all
NCT01099358 2019-09-26

Study in Advanced Solid Tumors

Eli Lilly and Company

Phase 2 Completed
47 enrolled 15 charts
Head & NeckSarcoma

Carcinoma, Head and Neck Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡